Bayer hits Mylan with Nexavar lawsuit
22-12-2015
Bayer seeks to block Nexavar generic at Delaware court
03-02-2015
30-10-2017
miodrag ignjatovic / iStockphoto.com
Bayer Healthcare and Mylan have settled their differences over a generic version of Bayer’s liver cancer drug Nexavar (sorafenib tosylate).
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Bayer, Bayer Healthcare, Mylan, ANDA, generics, Nexavar, patent, patent infringement, settlement